COVID-19 outcomes for patients on immunosuppressive drugs on par with non-immunosuppressed patients
Researchers create an animal model for studying GPI anchor deficiencies
7 January 2021Even before COVID-19, doctors faced online harassment, including death threats. The pandemic makes it worse
7 January 2021COVID-19 outcomes for patients on immunosuppressive drugs on par with non-immunosuppressed patients
People taking immunosuppressive drugs to prevent organ transplant rejection or to treat inflammatory or autoimmune diseases do not fare worse than others on average when they are hospitalized with COVID-19, according to a study from researchers at the Johns Hopkins Bloomberg School of Public Health.
